Skip to main content

Table 3 Differential analyses across all equity characteristics

From: Equity effects of children’s physical activity interventions: a systematic scoping review

Differential analysis

By gender /Total

BMI

Ethnicity

SES

Place of residence

Religion

Total number of non-targeted studies

98

113

102

113

112

113

Location:

 Australasia

6/18 (33%)

3/23 (13%)

0/23 (0%)

1/23 (4%)

0/23 (0%)

0/23 (0%)

 European

25/40 (63%)

4/44 (9%)

1/43 (2%)

5/44 (11%)

1/43 (2%)

0/44 (0%)

 North American

10/34 (29%)

7/40 (18%)

0/30 (0%)

1/40 (3%)

0/40 (0%)

0/40 (0%)

 Other

4/6 (67%)

1/6 (17%)

0/6 (0%)

0/6 (0%)

0/6 (0%)

0/6 (0%)

Publication year:

 2004 & earlier

2/6 (33%)

0/8 (0%)

0/4 (0%)

0/8 (0%)

0/8 (0%)

0/8 (0%)

 2005–2009

10/18 (56%)

2/21 (10%)

0/21 (0%)

0/21 (0%)

0/21 (0%)

0/21 (0%)

 2010–2014

25/54 (46%)

12/63 (19%)

1/57 (2%)

6/63 (10%)

0/62 (0%)

0/63 (0%)

 2015 & above

9/20 (45%)

1/21 (5%)

0/20 (0%)

1/21 (5%)

1/21 (5%)

0/21 (0%)

PA only or multi-behaviour intervention:

 PA only

27/58 (47%)

7/66 (11%)

0/64 (0%)

2/66 (3%)

1/46 (2%)

0/66 (0%)

 Multi-behaviour

19/40 (48%)

8/47 (17%)

1/37 (3%)

5/47 (11%)

0/66 (0%)

0/47 (0%)

Intervention setting:

 

 Home based

23/55 (42%)

8/63 (13%)

0/54 (0%)

5/63 (8%)

1/62 (2%)

0/63 (0%)

 School based

41/74 (55%)

11/84 (13%)

1/78 (1%)

6/84 (7%)

1/83 (1%)

0/84 (0%)

 Community  based

12/28 (43%)

6/34 (18%)

0/29 (0%)

2/34 (6%)

1/33 (3%)

0/34 (0%)

 Health-care based

3/3 (100%)

0/3 (0%)

0/3 (0%)

0/3 (0%)

0/3 (0%)

0/3 (0%)

Age, children vs adolescents:

 Children

34/78 (44%)

11/86 (13%)

0/78 (0%)

5/86 (6%)

1/86 (1%)

0/86 (0%)

 Adolescents

12/20 (60%)

4/27 (15%)

1/24 (4%)

2/27 (7%)

0/26 (0%)

0/27 (0%)

Main intervention effect, any outcome:

 Main effect

46/90 (51%)

12/102 (12%)

1/92 (1%)

6/102 (6%)

1/101 (1%)

0/102 (0%)

 No main effect

0/8 (0%)

3/11 (27%)

0/10 (0%)

1/11 (9%)

0/11 (0%)

0/11 (0%)

Main intervention effect, objectively measured PA:

 Main effect

39/70 (56%)

10/75 (13%)

1/71 (1%)

5/75 (7%)

0/74 (0%)

0/75 (0%)

 No main effect

7/21 (33%)

5/38 (13%)

0/31 (0%)

2/38 (5%)

1/38 (3%)

0/38 (0%)

  1. Note: Denominators are not consistent as each row is restricted to the number of non-targeted trials, separated by each equity characteristic